Should patients with chronic hepatitis C who have normal ALT levels be treated
作者： Mark W. Russo , Robert S. Brown
DOI: 10.1007/S11894-001-0040-5
关键词:
摘要: Up to 25% of patients with chronic hepatitis C have persistently normal serum alanine aminotransferase (ALT) levels. Reports from some studies indicate that ALT levels are more likely be female and nondrinkers. Patients often mild disease on liver biopsy little or no fibrosis, but a small number may substantial fibrosis cirrhosis. Treatment interferon monotherapy has been disappointing. Combination therapy ribavirin is controversial, early clinical results shown good response rates. Currently, for HCV should based upon preferably done in the context trial.
springer.com
sci-hub.se 参考文章(19)
Balart L, Favrot D, Taylor B, Gholson Cf, Morgan K, Catinis G, Gonzalez E, Chronic hepatitis C with normal aminotransferase levels : A clinical histologic study The American Journal of Gastroenterology. ,vol. 92, pp. 1788- 1792 ,(1997)
M. Mazen Jamal, Anurag Soni, Patrick G. Quinn, Donald E. Wheeler, Sanjeev Arora, David E. Johnston, Clinical features of hepatitis C–infected patients with persistently normal alanine transaminase levels in the southwestern United States Hepatology. ,vol. 30, pp. 1307- 1311 ,(1999) , 10.1002/HEP.510300526
Angelo Sangiovanni, Rino Morales, GianCarlo Spinzi, MariaGrazia Rumi, Antonietta Casiraghi, Roberto Ceriani, Enrico Colombo, Maurizio Fossati, Alberto Prada, Enrico Tavani, Giorgio Minoli, Interferon alfa treatment of HCV RNA carriers with persistently normal transaminase levels : A pilot randomized controlled study Hepatology. ,vol. 27, pp. 853- 856 ,(1998) , 10.1002/HEP.510270330
ETSURO ORITO, MASASHI MIZOKAMI, KAORU SUZUKI, KEN-ICHI OHBA, TOMOYOSHI OHNO, MAKOTO MIZUNO, YOSHIHIKO IIJIMA, HIROSHI SAITOH, AKIRA NEMOTO, NOBUO NUKUTA, Interferon‐α therapy for individuals with normal serum alanine aminotransferase levels before treatment Journal of Gastroenterology and Hepatology. ,vol. 12, pp. 58- 61 ,(1997) , 10.1111/J.1440-1746.1997.TB00347.X
Shiro Murashima, Michio Sata, Hiroshi Suzuki, Seiji Noguchi, Kyuichi Tanikawa, Sequence Variation of the Hypervariable Region in HCV Carriers with Normal ALT Levels: A Comparison with Symptomatic Carriers Microbiology and Immunology. ,vol. 40, pp. 941- 947 ,(1996) , 10.1111/J.1348-0421.1996.TB01163.X
A Rossini, A Ravaggi, L Biasi, E Agostinelli, L Bercich, G B Gazzola, F Callea, E Radaeli, E Cariani, Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis Hepatology. ,vol. 26, pp. 1012- 1017 ,(1997) , 10.1002/HEP.510260432
Masafumi Naito, Norio Hayashi, Toyoki Moribe, Hideki Hagiwara, Eiji Mita, Yoshiyuki Kanazawa, Akinori Kasahara, Hideyuki Fusamoto, Takenobu Kamada, Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease Hepatology. ,vol. 22, pp. 407- 412 ,(1995) , 10.1002/HEP.1840220206
L Aldegheri, S Resta, F Montagnese, P Rossi, A Magrini, P Rigato, C Puoti, T Stati, Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels Hepatology. ,vol. 26, pp. 1393- 1398 ,(1997) , 10.1053/JHEP.1997.V26.PM0009397976
Nicholas C. Tassopoulos, Treatment of patients with chronic hepatitis C and normal ALT levels Journal of Hepatology. ,vol. 31, pp. 193- 196 ,(1999) , 10.1016/S0168-8278(99)80400-0
P Marcellin, S Levy, S Erlinger, Therapy of hepatitis C: Patients with normal aminotransferase levels Hepatology. ,vol. 26, ,(1997) , 10.1002/HEP.510260723